Cancer Monthly Advises Actos Users to Know the Symptoms of Bladder...
In the wake of a federal jury’s decision to award $9 billion to a man who developed bladder cancer after using the diabetes drug Actos, Cancer Monthly says patients who took Actos should recognize the...(PRWeb April 17, 2014)Read the full story at http://www.prweb.com/releases/2014/04/prweb11766224.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: Actos | Bladder Cancer | Cancer | Cancer & Oncology | Diabetes | Endocrinology | Pharmaceuticals